Follow
Luc Furic
Luc Furic
Peter MacCallum Cancer Centre
Verified email at petermac.org - Homepage
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13120*2021
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
L Furic, L Rong, O Larsson, IH Koumakpayi, K Yoshida, A Brueschke, ...
Proceedings of the National Academy of Sciences 107 (32), 14134-14139, 2010
5962010
Mammalian Staufen1 recruits Upf1 to specific mRNA 3′ UTRs so as to elicit mRNA decay
YK Kim, L Furic, L DesGroseillers, LE Maquat
Cell 120 (2), 195-208, 2005
5902005
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
N Robichaud, SV del Rincon, B Huor, T Alain, LA Petruccelli, J Hearnden, ...
Oncogene 34 (16), 2032-2042, 2015
2752015
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ...
Science translational medicine 11 (478), eaau5758, 2019
2592019
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases
BW Konicek, JR Stephens, AM McNulty, N Robichaud, RB Peery, ...
Cancer research 71 (5), 1849-1857, 2011
2472011
Staufen1 regulates diverse classes of mammalian transcripts
YK Kim, L Furic, M Parisien, F Major, L DesGroseillers, LE Maquat
The EMBO journal 26 (11), 2670-2681, 2007
2452007
nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs
V Gandin, L Masvidal, L Hulea, SP Gravel, M Cargnello, S McLaughlan, ...
Genome research 26 (5), 636-648, 2016
2192016
Staufen2 isoforms localize to the somatodendritic domain of neurons and interact with different organelles
TF Duchaîne, I Hemraj, L Furic, A Deitinghoff, MA Kiebler, ...
Journal of cell science 115 (16), 3285-3295, 2002
1692002
A genome-wide approach identifies distinct but overlapping subsets of cellular mRNAs associated with Staufen1-and Staufen2-containing ribonucleoprotein complexes
L Furic, M Maher-Laporte, L DesGroseillers
Rna 14 (2), 324-335, 2008
1482008
p53-dependent translational control of senescence and transformation via 4E-BPs
E Petroulakis, A Parsyan, RJO Dowling, O LeBacquer, Y Martineau, ...
Cancer cell 16 (5), 439-446, 2009
1342009
Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E
B Herdy, M Jaramillo, YV Svitkin, AB Rosenfeld, M Kobayashi, D Walsh, ...
Nature immunology 13 (6), 543-550, 2012
1282012
AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965
TA Dite, CG Langendorf, A Hoque, S Galic, RJ Rebello, AJ Ovens, ...
Journal of Biological Chemistry 293 (23), 8874-8885, 2018
1232018
Cross-talk between protein synthesis, energy metabolism and autophagy in cancer
LM Lindqvist, K Tandoc, I Topisirovic, L Furic
Current opinion in genetics & development 48, 104-111, 2018
1222018
mTORC1 and CK2 coordinate ternary and eIF4F complex assembly
V Gandin, L Masvidal, M Cargnello, L Gyenis, S McLaughlan, Y Cai, ...
Nature communications 7 (1), 11127, 2016
1032016
Therapeutic approaches targeting MYC-driven prostate cancer
RJ Rebello, RB Pearson, RD Hannan, L Furic
Genes 8 (2), 71, 2017
1022017
Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy
MG Lawrence, D Obinata, S Sandhu, LA Selth, SQ Wong, LH Porter, ...
European urology 74 (5), 562-572, 2018
972018
Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth
HB Pearson, J Li, VS Meniel, CM Fennell, P Waring, KG Montgomery, ...
Cancer discovery 8 (6), 764-779, 2018
922018
Generally applicable transcriptome-wide analysis of translation using anota2seq
C Oertlin, J Lorent, C Murie, L Furic, I Topisirovic, O Larsson
Nucleic acids research 47 (12), e70-e70, 2019
802019
The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer
RJ Rebello, E Kusnadi, DP Cameron, HB Pearson, A Lesmana, JR Devlin, ...
Clinical Cancer Research 22 (22), 5539-5552, 2016
792016
The system can't perform the operation now. Try again later.
Articles 1–20